Endocrine HealthWellness & Preventive Health
Insulin-like Growth Factor-binding Protein 3 (IGFBP-3)
What is Insulin-like Growth Factor-binding Protein 3 (IGFBP-3) and why is it important?
<p>The insulin-like growth factor (IGF) system plays a
critical role in the growth and differentiation of normal and
malignant cells. The components of the IGF system include growth
hormone (GH), IGF-I and II, type I and II receptors, IGF binding
proteins and proteases. IGF binding proteins were first identified
for their high affinity interactions with IGF-I and
IGF-II.</p><p>IGFBP-3 is the most abundant IGFBP
species in circulation and binds 75% to 90% of circulating IGF-I
in a ternary complex consisting of IGFBP-3, IGF-I and acid-labile
subunit (ALS). IGFBP-3 modulates the activity of IGF-1 and to
increase their half lives. It has been postulated that IGFBP-3 is
regulated by GH and originates in the liver as low levels were
observed in patients with impaired hepatic
function.</p><p>IGFBP-3 has historically been used in
the investigation of growth hormone deficiency, acromegaly,
hypopituitarism and to monitor recombinant GH therapy. IGFBP-3 is
known to modulate the actions of IGFs in circulation as and at the
IGF-1 receptor. IGFBP-3 has also been shown to exhibit distinct
biological effects independent of the IGF/IGF-1 receptor axis.
Recent studies have impaired interaction of IGFBP-3 with a variety
of proteins or signaling cascades critical to cell cycle control
and apoptosis; however, the actual mechanism of IGFBP-3 action is
unclear.</p>
When to consider Insulin-like Growth Factor-binding Protein 3 (IGFBP-3)?
- If a child exhibits stunted growth or short stature, potentially indicating growth hormone deficiency.
- If an adult experiences symptoms such as unexplained fatigue, reduced muscle mass, increased body fat, or bone density issues, which could be linked to growth hormone imbalance.
- For individuals with signs of growth hormone excess, such as enlarged hands and feet, changes in facial features, or excessive sweating.
- If you have been diagnosed with hypopituitarism or are undergoing treatment for growth hormone-related conditions.
Who benefits from Insulin-like Growth Factor-binding Protein 3 (IGFBP-3)?
- Individuals suspected of having growth hormone (GH) deficiency or excess (like acromegaly).
- Patients being monitored during recombinant growth hormone therapy.
- Those with suspected hypopituitarism, a condition affecting the pituitary gland's hormone production.
- Children with growth concerns or adults with symptoms related to growth hormone imbalance.
When is the Insulin-like Growth Factor-binding Protein 3 (IGFBP-3) used?
Commonly Used For Diagnosis Of
The Insulin-like Growth Factor-binding Protein 3 (IGFBP-3) test is a key diagnostic tool in assessing disorders related to growth hormone (GH) secretion and activity. As IGFBP-3 levels are largely dependent on GH, this test is instrumental in identifying:
- Growth Hormone Deficiency: Particularly in children exhibiting stunted growth or adults with symptoms such as unexplained fatigue, altered body composition (reduced muscle, increased fat), or decreased bone density.
- Acromegaly/Gigantism: For individuals presenting with signs of excessive growth hormone production, such as enlarged hands and feet, coarsened facial features, or excessive sweating.
- Hypopituitarism: A condition where the pituitary gland produces insufficient hormones, including growth hormone. IGFBP-3 levels can help assess overall pituitary function.
- Monitoring of Recombinant Growth Hormone Therapy: To ensure effective treatment and appropriate dosing for individuals receiving growth hormone supplementation.
Important Considerations
Please note that several factors, including age, nutritional status, and liver or kidney function, can influence IGFBP-3 levels. It is crucial to discuss your test results with a healthcare provider to understand what they mean for your individual health and to determine the most appropriate course of action.